Filing Details

Accession Number:
0001123292-16-003077
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-19 16:28:07
Reporting Period:
2016-12-15
Filing Date:
2016-12-19
Accepted Time:
2016-12-19 16:28:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588972 Recro Pharma Inc. REPH Pharmaceutical Preparations (2834) 261523233
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1602327 Wayne Weisman C/O Recro Pharma, Inc.
490 Lapp Road
Malvern PA 19355
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-15 4,000 $6.53 4,000 No 4 P Direct
Common Stock Acquisiton 2016-12-16 3,000 $6.57 7,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.50 to $6.55, inclusive. The reporting person undertakes to provide to Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.55 to $6.61, inclusive. The reporting person undertakes to provide to Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.